Publications
Summary of publication
Australia’s investment in health in Papua New Guinea (PNG) for 2018-2023 was broadly guided by a five-year PNG Health Sector Portfolio Plan, known as the Health Portfolio Plan (HPP).
The HPP served as an umbrella for several separate agreements provided through a combination of modalities. These included technical assistance, projects directly managed by contractors, co-funding with multilateral institutions, and a direct funding agreement that exclusively used PNG government systems.
An independent mid-term review of the HPP, finalised in 2023, had two primary purposes:
- to assess the progress and performance of the HPP in progressing towards its end of investment outcomes, and
- to make recommendations on how HPP implementation could be enhanced in its remaining time, and to inform the development of a successor to the HPP.
The central recommendation of the review was to largely maintain the present priorities and direction of the HPP. The review also presented both short and longer-term recommendations to position DFAT and its PNG Health Portfolio for a future HPP.
Download publication
- Health Portfolio Plan Mid-Term Review (2022) Report [DOCX 3.8 MB]
- Health Portfolio Plan Mid-Term Review (2022) Report [PDF 1.7 MB]
DFAT Management Response
DFAT agrees with the central recommendation of the review to largely maintain the present priorities and direction of the HPP and agrees in full or in part with all the individual recommendations of the review.
At the time of response, many of the review’s recommendations were already being implemented or are being designed into the next HPP, which we anticipate will be finalised and in place in 2024.